APR 14, 2015 10:33 AM PDT

T-Cell "Cops" Help Foil Runaway Immune System

WRITTEN BY: Judy O'Rourke
Scientists have found an alternative track for potentially aggressive T-cells in which the cells can be recruited to help "police" over-active immune responses via the molecule CD, instead of leading to autoimmune disease.

The immune system keeps us healthy by avoiding responses that are too lax or too extreme (eg, people get sick if their immune system inefficiently battles pathogens such as bacteria and viruses, and conversely, if their immune system is too robust, they may develop autoimmune diseases).
Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor.
Daniel Hawiger, MD, PhD, assistant professor of molecular microbiology and immunology, Saint Louis University, and colleagues from his lab had a breakthrough in understanding how regulatory T cells (which police other T cells' responses) develop. T-cells, the immune system's soldiers, recognize between self and nonself.

During the T-cell "learning" process, a group of them always develops that remain self-reactive. They could foist their attacks on the body's own cells, which can lead to autoimmune diseases. "There is a need to keep those T-cells in check, because otherwise we would have a runaway immune system," Hawiger says.

The immune system generally keeps self-reactive T-cells under control by deleting them. But, some of them may be useful for the immune system in recognizing foreign pathogens. The molecule CD5 helps these self-reactive T-cells survive and stay under the radar.

The researchers discovered that increased expression of CD5 also serves as a safeguard against autoimmunity by training potentially auto-aggressive cells to become regulatory T cells, lessening the risk of autoimmune disease. "What we discovered is that there is a mechanism that can specifically push those self-reactive T-cells to become ‘T-cell policemen,' " Hawiger says. "They become T-cells that can regulate other T-cells' responses."

The article "CD5 Instructs Extrathymic Regulatory T Cell Development in Response to Self and Tolerizing Antigens" is published in the March issue of the journal Immunity.

[Source: St Louis University]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
OCT 12, 2021
Drug Discovery & Development
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
OCT 12, 2021
Preventing future pandemics - Scientists developing broadly protective vaccines against coronaviruses
Researchers at Japan’s Osaka University recently developed and tested a novel vaccine that may protect a ...
NOV 11, 2021
Immunology
Some Patients Left Vulnerable to COVID Even After Getting Vaccinated
NOV 11, 2021
Some Patients Left Vulnerable to COVID Even After Getting Vaccinated
Global vaccination efforts continue in the backdrop of the ongoing pandemic. However, new studies demonstrate how severa ...
DEC 09, 2021
Cannabis Sciences
Considering Cannabinoids as a COVID-19 Treatment
DEC 09, 2021
Considering Cannabinoids as a COVID-19 Treatment
Research suggests that Cannabis sativa-derived cannabinoids – such as cannabidiol (CBD), Δ9tetrahydrocannabi ...
JAN 06, 2022
Immunology
Worryingly High Levels of Free Radicals in COVID Patients
JAN 06, 2022
Worryingly High Levels of Free Radicals in COVID Patients
  COVID-19 infections trigger widespread oxidative damage, says new research by scientists from the Baylor College ...
JAN 13, 2022
Health & Medicine
Studies Confirm Omicron Itself, Not Previous Immunity From Infections or Vaccines, Is Responsible for Milder Symptoms
JAN 13, 2022
Studies Confirm Omicron Itself, Not Previous Immunity From Infections or Vaccines, Is Responsible for Milder Symptoms
Despite initial fears last November that genetic changes to the Omicron variant might spell disaster for humans, rodent ...
JAN 14, 2022
Drug Discovery & Development
Repurposing Drugs 101
JAN 14, 2022
Repurposing Drugs 101
Drug development is expensive. Taking into account costs of failed trials, the average drug costs $985 million to resear ...
Loading Comments...